Moderna (MRNA) Reports Q2 Revenues Below Consensus
Tweet Send to a Friend
Moderna (NASDAQ: MRNA) reported Q2 revenue for the quarter came in at $13.08 million versus the consensus estimate of $18.8 ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE


